Clinical Trial Update: Integration of mHEALTH Into the Care of Patients With Sickle Cell Disease to Increase Hydroxyurea Utilization [NA]

View source ↗

Summary

Clinical trial update on integrating mHealth into care to increase hydroxyurea utilization in sickle cell disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Sickle Cell Disease | NA | Status: COMPLETED | Results posted: 2023-11-22